| 000 | 01570 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250514025500.0 | ||
| 264 | 0 | _c20020404 | |
| 008 | 200204s 0 0 eng d | ||
| 022 | _a0008-543X | ||
| 024 | 7 |
_a10.1002/cncr.10219 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPickles, Tom | |
| 245 | 0 | 0 |
_aTestosterone recovery following prolonged adjuvant androgen ablation for prostate carcinoma. _h[electronic resource] |
| 260 |
_bCancer _cJan 2002 |
||
| 300 |
_a362-7 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 |
_aAdenocarcinoma _xblood |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAndrogen Antagonists _xtherapeutic use |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Hormonal _xtherapeutic use |
| 650 | 0 | 4 | _aChemotherapy, Adjuvant |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPituitary Gland _xphysiology |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aProstatic Neoplasms _xblood |
| 650 | 0 | 4 | _aRadiotherapy, Adjuvant |
| 650 | 0 | 4 |
_aTestis _xphysiology |
| 650 | 0 | 4 |
_aTestosterone _xblood |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aAgranovich, Alex | |
| 700 | 1 | _aBerthelet, Eric | |
| 700 | 1 | _aDuncan, Graeme G | |
| 700 | 1 | _aKeyes, Mira | |
| 700 | 1 | _aKwan, Winkle | |
| 700 | 1 | _aMcKenzie, Michael R | |
| 700 | 1 | _aMorris, W James | |
| 773 | 0 |
_tCancer _gvol. 94 _gno. 2 _gp. 362-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/cncr.10219 _zAvailable from publisher's website |
| 999 |
_c11806220 _d11806220 |
||